Skip to content Skip to search Skip to footer
WashU Medicine

Dominantly Inherited Alzheimer Network (DIAN)

Menu
  • Join the Registry
    • Individuals & Families
    • Researchers & Health Professionals
  • For Families
    • Genetic Counseling & Testing
    • Family Conferences
    • Video Gallery
    • Family Voices
    • DIAN in Latin America
    • EXR Newsletter
    • Webinars
    • Resources
    • Brain Donation
    • Message from Our Directors
  • Observational Study
    • Obs Study Sites
    • Study Description
    • Participation
    • Procedures
    • Advisory & Steering Committee
    • Funding: DIAN Obs Study
  • Clinical Trials
    • TU Participating Sites
    • Primary Prevention Trial
    • Secondary Prevention Trial
    • Research Updates
    • Funding
    • DIAN-TU History
  • Our Research
    • For Investigators
    • Our Collaborators
    • Research Fellows
    • DIAN Symposium
    • Pharma Consortium
    • Publications
    • Latin America Expansion
  • About us
    • The DIAN Team
    • Committees
    • Contact
  • News & Updates

Category: Advancements in Alzheimers disease

New blood test diagnoses Alzheimer’s disease and measures how far it’s progressed (Links to an external site)

April 1, 2025April 7, 2025

The new test could also help confirm whether Alzheimer’s or another condition is causing a person’s symptoms.

Predicting cognitive decline in Alzheimer’s (Links to an external site)

March 31, 2025April 3, 2025
(Photo: Getty Images)

New tests of blood and spinal fluid can show how far Alzheimer’s has progressed and how fast a patient’s memory will decline.

Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens? (Links to an external site)

February 6, 2025February 14, 2025

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.

New drug targets for Alzheimer’s identified from cerebrospinal fluid (Links to an external site)

November 14, 2024December 11, 2024
(Photo: Getty Images)

Study pegs certain cellular activities to driving Alzheimer’s disease. Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.

The New Age of Alzheimer’s (Links to an external site)

April 18, 2024October 7, 2024

The soaring burden of dementia threatens global health. Science is paving new paths to solutions.

Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site)

August 4, 2023June 18, 2024

Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach (Links to an external site)

May 8, 2023

Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site)

April 7, 2023

Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site)

February 3, 2023February 3, 2023

FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site)

January 7, 2023

Posts navigation

1 of 2
Next Page

DIAN

Dominantly Inherited Alzheimer Network

WashU Medicine

660 S. Euclid Ave.

Campus Box 8111

St. Louis, MO 63110

 

Contact Us

Links

  • Investigator Resources
  • Current Participating Sites
  • DIAN Research Updates

Make a Difference

Your thoughtful contribution enables us to continue researching possible treatments and ultimately cures for this devastating disease.

DONATE

©2025 Washington University in St. Louis